Brief: Haemonetics Announces Sale Of Whole Blood Assets To Gvs for Up To $67.1 Mln
03/12/2024 06:19
Dec 3 (Reuters) - Haemonetics Corp HAE.N :
* HAEMONETICS ANNOUNCES SALE OF WHOLE BLOOD ASSETS TO GVS,
S.P.A
* HAEMONETICS CORP - DEAL VALUED AT UP TO $67.1 MILLION
Source text: ID:nPncb417Ja
Further company coverage: HAE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GVS
See all newsGoldman Sachs cuts GVS to 'neutral' from 'buy' on limited upside
Brief: Gvs Expects Raises 2026 Guidance To Mid-Single-Digit Organic Revenue Growth
Brief: Gvs H1 Net Profit Adjusted €23.8 Mln
Brief: Gvs SpA - Announces Final Results Of Public Tender Offer For Treasury Shares, To Hold 6.07 Mln Shares, 3.21% Of Share Capital
Brief: Italy's Market Watchdog Consob Approves GVS Voluntary Partial Tender Offer Document